Sichuan Kelun Pharmaceutical is a leading Chinese pharmaceutical company specializing in the research, development, manufacturing, and distribution of high-quality medicines. The company offers a wide range of pharmaceuticals, including injections, infusion solutions, and antibiotics, to improve healthcare in China and globally. With a strong focus on innovation, Sichuan Kelun Pharmaceutical makes significant contributions to modern medicine.
Date confirmed from the official Chinese exchange disclosure timetable.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Sichuan Kelun Pharmaceutical is scheduled to report its next quarterly earnings on 08/27/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Sichuan Kelun Pharmaceutical last reported quarterly earnings on 4/29/2026 (Q1 2026). Earnings per share (EPS) came in at 0.35 CNY.
Across its last 3 earnings reports, Sichuan Kelun Pharmaceutical stock moved by ±2.6% on average the following day. The largest reaction was +4.6% on 04/29/2026; 1 of 3 reactions were positive.
Sichuan Kelun Pharmaceutical has beaten analyst EPS estimates in 1 of its last 4 evaluated quarters (beat rate: 25%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 4 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.